Mighty Mice

Stephen Hayward / Getty

The study Researchers at the biotech firm Novocell report the first successful use of human embryonic stem cells (HESCs) in treating a disease--diabetes--in mice. After generating HESCs from excess fertility-clinic embryos, the scientists cultured the cells for 12 days in a medium that directed them to become pancreatic cells. These were transplanted into mice whose own pancreatic cells had been deliberately destroyed, making them insulin-deficient. Within 45 days, new cells began producing fresh insulin.

What this means for us It's just a first step. In humans with Type 1 diabetes, the body destroys pancreatic cells, so the stem cells might be...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!